InvestorsObserver
×
News Home

Is Precigen Inc (PGEN) a Good Choice in Biotechnology Thursday?

Thursday, November 16, 2023 01:51 PM | InvestorsObserver Analysts

Mentioned in this article

Is Precigen Inc (PGEN) a Good Choice in Biotechnology Thursday?

A rating of 38 puts Precigen Inc (PGEN) near the middle of the Biotechnology industry according to InvestorsObserver. Precigen Inc's score of 38 means it scores higher than 38% of stocks in the industry. Precigen Inc also received an overall rating of 39, putting it above 39% of all stocks. Biotechnology is ranked 43 out of the 148 industries.

Overall Score - 39
PGEN has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on PGEN!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 39 would rank higher than 39 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Precigen Inc Stock Today?

Precigen Inc (PGEN) stock has risen 2.83% while the S&P 500 is lower by -0.21% as of 1:42 PM on Thursday, Nov 16. PGEN has gained $0.03 from the previous closing price of $1.06 on volume of 1,273,961 shares. Over the past year the S&P 500 is higher by 13.50% while PGEN is lower by -40.44%. PGEN earned $0.14 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 7.6. Click Here to get the full Stock Report for Precigen Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App